Microbiology
-
Targeted Drug Repurposing Against the SARS-CoV-2 E channel Identifies Blockers With in vitro Antiviral Activity
This article has 3 authors:Reviewed by ScreenIT
-
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
This article has 15 authors:Reviewed by ScreenIT
-
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
This article has 31 authors:Reviewed by ScreenIT
-
SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
This article has 6 authors:Reviewed by ScreenIT
-
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual
This article has 12 authors:Reviewed by ScreenIT
-
Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants
This article has 3 authors:Reviewed by ScreenIT
-
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2
This article has 14 authors:Reviewed by ScreenIT
-
In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays
This article has 6 authors:Reviewed by ScreenIT
-
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
This article has 46 authors:Reviewed by ScreenIT
-
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells
This article has 8 authors:Reviewed by ScreenIT